tiprankstipranks
Trending News
More News >
Faron Pharmaceuticals Oy (GB:FARN)
LSE:FARN
UK Market

Faron Pharmaceuticals Oy (FARN) Income Statement

Compare
44 Followers

Faron Pharmaceuticals Oy Income Statement

Last quarter (Q4 2022), Faron Pharmaceuticals Oy's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Faron Pharmaceuticals Oy's net income was $―. See Faron Pharmaceuticals Oy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 803.00K$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 301.00K$ 307.00K$ 283.00K$ 238.00K$ 100.00K
EBITDA
$ -27.05M$ -20.96M$ -16.79M$ -13.10M$ -19.86M
Operating Income
$ -27.43M$ -21.11M$ -16.65M$ -13.10M$ -19.65M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -28.73M$ -21.19M$ -16.94M$ -13.26M$ -20.09M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Faron Pharmaceuticals Oy Earnings and Revenue History